| Ident. | Authors (with country if any) | Title |
|---|
| 000039 (2011) |
Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon] | Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders |
| 000056 (2015) |
Yuliya Hellwig [Allemagne] ; Young E. Yoo [Allemagne] ; Marie L. Re [Allemagne] ; Oliver Andres [Allemagne] ; Matthias Braun [Allemagne] ; Paul G. Schlegel [Allemagne] ; Matthias Wölfl [Allemagne] | Fulminant skin GvHD with a cytokine pattern resemblant of cytokine release syndrome successfully treated with multimodal immunosuppression including tocilizumab |
| 000058 (2014) |
Lucie M. Turcotte [États-Unis] ; Colleen K. Correll ; Robyn C. Reed ; Christopher L. Moertel | Sustained remission of severe multicentric castleman disease following multiagent chemotherapy and tocilizumab maintenance |
| 000069 (2016) |
Nozomu Yanaihara [Japon] ; Yukihiro Hirata [Japon] ; Noriko Yamaguchi [Japon] ; Yukiko Noguchi [Japon] ; Misato Saito [Japon] ; Chie Nagata [Japon] ; Satoshi Takakura [Japon] ; Kyosuke Yamada [Japon] ; Aikou Okamoto [Japon] | Antitumor effects of interleukin‐6 (IL‐6)/interleukin‐6 receptor (IL‐6R) signaling pathway inhibition in clear cell carcinoma of the ovary |
| 000172 (2011) |
Maneesh Gogia [États-Unis] ; Daniel E. Furst [États-Unis] | Rheumatoid arthritis and pregnancy: Disease activity, pregnancy outcomes, and treatment options during pregnancy and lactation |
| 000179 (2009) |
Masahiko Mihara [Japon] ; Yoshiyuki Ohsugi [Japon] ; Tadamitsu Kishimoto | Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti‐interluekin‐6 receptor antibody |
| 000290 (2011) |
Yiyun Yu [États-Unis, République populaire de Chine] ; Antonio La Cava [États-Unis] | Current drugs in systemic lupus erythematosus |
| 000326 (2015) |
Takeshi Sainoh [Japon] ; Sumihisa Orita [Japon] ; Masayuki Miyagi [Japon] ; Yoshihiro Sakuma [Japon] ; Kazuyo Yamauchi [Japon] ; Miyako Suzuki [Japon] ; Go Kubota [Japon] ; Yasuhiro Oikawa [Japon] ; Kazuhide Inage [Japon] ; Jun Sato [Japon] ; Kazuki Fujimoto [Japon] ; Yasuhiro Shiga [Japon] ; Gen Inoue [Japon] ; Yasuchika Aoki [Japon] ; Kazuhisa Takahashi [Japon] ; Seiji Ohtori [Japon] | Interleukin‐6 and interleukin‐6 receptor expression, localization, and involvement in pain‐sensing neuron activation in a mouse intervertebral disc injury model |
| 000570 (2012) |
Zhifeng Wei [République populaire de Chine] ; Fengyun Wang [République populaire de Chine] ; Jie Song [République populaire de Chine] ; Qian Lu [République populaire de Chine] ; Peng Zhao [République populaire de Chine] ; Yufeng Xia [République populaire de Chine] ; Guixin Chou [République populaire de Chine] ; Zhengtao Wang [République populaire de Chine] ; Yue Dai [République populaire de Chine] | Norisoboldine inhibits the production of interleukin‐6 in fibroblast‐like synoviocytes from adjuvant arthritis rats through PKC/MAPK/NF‐κB‐p65/CREB pathways |
| 000576 (2013) |
Marco Bigoni [Italie] ; Paola Sacerdote [Italie] ; Marco Turati [Italie] ; Silvia Franchi [Italie] ; Marta Gandolla [Italie] ; Diego Gaddi [Italie] ; Sarah Moretti [Italie] ; Daniele Munegato [Italie] ; Carlo A. Augusti [Italie] ; Elena Bresciani [Italie] ; Robert J. Omeljaniuk [Canada] ; Vittorio Locatelli [Italie] ; Antonio Torsello [Italie] | Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury |
| 000584 (2012) |
Chia Chi Sun [États-Unis] ; Valentina Vaja [États-Unis, Italie] ; Jodie L. Babitt [États-Unis] ; Herbert Y. Lin [États-Unis] | Targeting the hepcidin–ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation |
| 000A87 (2011) |
Rajkumar Venkatramani [États-Unis] ; Nina S. Ma [États-Unis] ; Pisit Pitukcheewanont [États-Unis] ; Marcio H. Malogolowkin [États-Unis] ; Leo Mascarenhas [États-Unis] | Gorham's disease and diffuse lymphangiomatosis in children and adolescents |
| 000B67 (2012) |
Sandeep Kumar [États-Unis] ; Mark A. Mitchell [États-Unis] ; Bonita Rup [États-Unis] ; Satish K. Singh [États-Unis] | Relationship between potential aggregation‐prone regions and HLA‐DR‐binding T‐cell immune epitopes: Implications for rational design of novel and follow‐on therapeutic antibodies |
| 000C02 (2011) |
Ines Zidi [Tunisie, Arabie saoudite] ; Wissem Mnif [Tunisie] ; Aicha Bouaziz [Tunisie] ; Nidhal Ben Amor [Tunisie, Arabie saoudite] | Certolizumab pegol therapy of rheumatoid arthritis: Overview |
| 000F16 (2012) |
Mitsuru Ishizuka [Japon] ; Hitoshi Nagata [Japon] ; Kazutoshi Takagi [Japon] ; Yoshimi Iwasaki [Japon] ; Keiichi Kubota [Japon] | Preoperative thrombocytosis is associated with survival after surgery for colorectal cancer |
| 000F31 (2014) |
Marine Gilabert [France] ; Ezequiel Calvo [Canada] ; Ana Airoldi [France] ; Tewfik Hamidi [France] ; Vincent Moutardier [France] ; Olivier Turrini [France] ; Juan Iovanna [France] | Pancreatic Cancer‐Induced Cachexia Is Jak2‐Dependent in Mice |
| 000F41 (2012) |
Antonella De Luca [Italie] ; Luana Lamura [Italie] ; Marianna Gallo [Italie] ; Veronica Maffia [Italie] ; Nicola Normanno [Italie] | Mesenchymal stem cell‐derived interleukin‐6 and vascular endothelial growth factor promote breast cancer cell migration |
| 001241 (2010) |
Iranaia Assunção-Miranda [Brésil] ; Marcelo T. Bozza [Brésil] ; Andrea T. Da Poian [Brésil] | Pro‐inflammatory response resulting from sindbis virus infection of human macrophages: Implications for the pathogenesis of viral arthritis |
| 001242 (2015) |
Maya Suzuki [États-Unis] ; Kevin J. Curran [États-Unis] ; Nai-Kong V. Cheung [États-Unis] | Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology |
| 001253 (2011) |
Jinqi Liu [États-Unis] ; Huseyin Mehmet [États-Unis] | Emerging therapies in the treatment of rheumatoid arthritis |
| 001254 (2013) |
Velin Z. Spassov [États-Unis] ; Lisa Yan [États-Unis] | pH‐selective mutagenesis of protein–protein interfaces: In silico design of therapeutic antibodies with prolonged half‐life |
